PureTech Health (CHIX:PRTCL) GF Value Rank: 2 (As of Jul. 12, 2026) — 60% Below Median


CHIX:PRTCL PureTech Health PLC CHIX:PRTCL
66 GF Score
Price £1.20
GF Value £5.34
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is PureTech Health GF Value Rank?

PureTech Health CHIX:PRTCL -0.17% 66 GF Value Rank is 2 as of Jul. 12, 2026, which is 60% below its 10-year median of 5.00. GuruFocus rates CHIX:PRTCL with a GF Score™ of 66/100 and a GF Value™ of £5.34 (Possible Value Trap). The stock has 3 warning signs investors should review.

PureTech Health has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

PureTech Health GF Value Rank Related Terms

CHIX:PRTCL vs VRTX, REGN, ALNY: GF Value Rank Comparison

For the Biotechnology subindustry, PureTech Health's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PureTech Health GF Value Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's GF Value Rank distribution charts can be found below:

* The bar in red indicates where PureTech Health's GF Value Rank falls into.


CHIX:PRTCL
66GF Score
PureTech Health PLC CHIX:PRTCL
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
PureTech Health (CHIX:PRTCL) has a GF Value Rank of 2 as of Jul. 12, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on PureTech Health and its competitors. This is 60% below median its historical median of 5.00. Over the past decade, PureTech Health's GF Value Rank has ranged from 1.00 to 10.00.
Is PureTech Health's GF Value Rank too high?
PureTech Health's current GF Value Rank of 2 is 60% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, PureTech Health has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PureTech Health's GF Value Rank compare to VRTX and REGN?
PureTech Health's GF Value Rank of 2 can be compared against companies in the Biotechnology industry. Historically, PureTech Health's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Biotechnology company?
A good GF Value Rank depends on the Biotechnology industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on PureTech Health and its competitors. PureTech Health's current GF Value Rank is 2, which is 60% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PureTech Health stock overvalued right now?
Based on GuruFocus' analysis, PureTech Health (CHIX:PRTCL) is currently considered Possible Value Trap. The stock's GF Value™ is £5.34, compared to a current price of £1.20 — trading 77.6% below its estimated fair value. The current GF Value Rank is 2, which is 60% below median its 10-year median of 5.00. PureTech Health's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For PureTech Health (CHIX:PRTCL), the current GF Value Rank is 2 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PureTech Health (CHIX:PRTCL) Overvalued in 2026?

Based on GuruFocus' analysis, PureTech Health stock appears to be undervalued. The current stock price of £1.20 is trading 77.6% below its estimated GF Value™ of £5.34. GuruFocus considers PureTech Health to be Possible Value Trap.

Key valuation signals for CHIX:PRTCL:

  • GF Value Rank: 2 (60% below median its 10-year median of 5.00)
  • GF Value™: £5.34 vs. price of £1.20 (77.6% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the CHIX:PRTCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PureTech Health Business Description

Address 6 Tide Street, Suite 400, Boston, MA, USA, 02210
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
66GF Score

Get the complete analysis for CHIX:PRTCL

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.20
Price
£5.34
GF Value